Edition:
United Kingdom

BrightPath Biotherapeutics Co Ltd (4594.T)

4594.T on Tokyo Stock Exchange

231JPY
6:00am GMT
Change (% chg)

¥-6 (-2.53%)
Prev Close
¥237
Open
¥232
Day's High
¥240
Day's Low
¥231
Volume
505,600
Avg. Vol
561,203
52-wk High
¥968
52-wk Low
¥231

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Sep 20.31 -10.368
Jun 122.13 -13.939
FY 2018 Mar '18 107.78 -9.786
Dec 63.95 -13.060
Sep 92.04 -11.369
Jun 90.64 -7.075
FY 2017 Mar '17 98.18 -11.022
Dec 114.40 -6.995
Sep 123.89 -8.560
Jun 193.14 -5.967
FY 2016 Mar '16 209.44 -6.322
Dec 197.21 -6.553
Sep 209.59 -12.508
Jun 206.31 -10.991
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.62 33.60
P/E High - Last 5 Yrs. -- 301.03 45.05
P/E Low - Last 5 Yrs. -- 83.19 24.37
Beta -- 0.93 0.91
Price to Sales (TTM) 39.68 119.20 5.69
Price to Book (MRQ) 3.42 14.53 5.11
Price to Tangible Book (MRQ) 3.43 13.73 6.54
Price to Cash Flow (TTM) -- 65.35 23.53
% Owned Institutions -- 13.41 1.86

Dividends

  Company industry sector
Dividend Yield -- 0.42 1.48
Dividend Yield - 5 Year Avg -- 0.33 1.50
Dividend 5 Year Growth Rate -- 2.84 5.08
Payout Ratio(TTM) -- 25.28 43.86

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -53.07 376.86 7.43
Sales (TTM) vs TTM 1 Yr. Ago -47.23 95.69 5.86
Sales - 5 Yr. Growth Rate -- 28.71 10.16
EPS (MRQ) vs Qtr. 1 Yr. Ago -18.58 28.13 21.20
EPS (TTM) vs TTM 1 Yr. Ago -7.12 -- --
EPS - 5 Yr. Growth Rate -- 32.53 10.63
Capital Spending - 5 Yr. Growth Rate -- 35.83 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 49.32 2.10 2.26
Current Ratio (MRQ) 49.83 5.34 3.09
LT Debt to Equity (MRQ) 0.00 35.90 11.53
Total Debt to Equity (MRQ) 0.00 37.76 15.71
Interest Coverage (TTM) -- -89.20 32.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 1.35 40.11 54.07
Gross Margin - 5 Yr. Avg. -- 48.16 51.83
EBITD Margin (TTM) -266.70 -- --
EBITD - 5 Yr. Avg -- -543.12 11.80
Operating Margin (TTM) -278.16 -781.99 4.84
Operating Margin - 5 Yr. Avg. -- -563.67 7.45
Pre-Tax Margin (TTM) -278.28 -746.11 5.82
Pre-Tax Margin - 5 Yr. Avg. -- -568.92 7.86
Net Profit Margin (TTM) -279.95 -747.08 2.07
Net Profit Margin - 5 Yr. Avg. -- -571.62 4.10
Effective Tax Rate (TTM) -- 25.08 23.39
Effective Tax Rate - 5 Yr. Avg. -- 20.19 24.13

Efficiency

  Company industry sector
Revenue/Employee (TTM) 11,543,460 22,492,720 905,570,157
Net Income/Employee (TTM) -32,315,890 826,541 107,319,415
Receivable Turnover (TTM) 4.89 19.51 5.95
Inventory Turnover (TTM) 9.86 2.77 3.63
Asset Turnover (TTM) 0.09 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -26.51 -2.02 11.52
Return on Assets - 5 Yr. Avg. -- 2.44 12.71
Return on Investment (TTM) -27.18 -0.65 15.05
Return on Investment - 5 Yr. Avg. -- 1.25 16.50
Return on Equity (TTM) -27.22 0.07 16.62
Return on Equity - 5 Yr. Avg. -- 1.76 17.61
  1 Year 3 Year 5 Year
Sales % -35.61 -17.21 --
EPS (TTM) % 7.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for BrightPath Biotherapeutics Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.58 1.61 65 58
13 Week -13.85 -17.94 25 60
26 Week -21.18 -30.40 29 79
52 Week -33.63 -46.74 27 46
YTD -34.58 -41.12 20 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.03%
# of Holders: 10
Total Shares Held: 2,105,960
3 Mo. Net Change: 2,700
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.